{
    "url_original": "https://www.wsj.com/articles/pfizer-nears-covid-19-vaccine-deal-with-u-s-to-supply-more-doses-11608681220?mod=business_lead_pos6",
    "url": "pfizer-nears-covid-19-vaccine-deal-with-u-s-to-supply-more-doses-11608681220",
    "title": "Pfizer Nears Covid-19 Vaccine Deal With U.S. to Boost Supply",
    "sub_head": "Company would provide 100 million more doses to bolster campaign under way in U.S.",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2020-12-22 19:33:00",
    "body": "The federal government is advancing toward a deal with  Pfizer Inc.  to secure 100 million more doses of the company’s Covid-19 vaccine, according to people familiar with the matter, an agreement that would bolster the vaccination campaign under way in the U.S.<br />Under the terms in discussion, Pfizer would provide the additional doses by July for nearly $2 billion, according to one person familiar with the discussions.<br />An agreement could be announced as soon as Wednesday, according to the person, though other people said they weren’t aware negotiations were that far along or were for 100 million doses.<br />The New York Times earlier reported that the U.S. was close to an agreement with Pfizer for additional doses.<br />In July, the U.S. government agreed to pay Pfizer and its German partner,  BioNTech  SE, $1.95 billion for the first 100 million doses of the vaccine, or $19.50 per dose, with options to buy an additional 500 million doses."
}